Quote:
Originally posted by Hank Chinaski
But if a company invests in labs and scientist and developing drugs that will be thrown away in 99% of the cases, it need some decent ROI to justify continuing.
|
Given that viagra was selling for what $60 a pill on manufacturing costs of probably less than 5c each, I'm pretty sure Pfizer was able to recover a fair amount of costs associated with that drug's development and a bunch of others' as well.
The fundamental proposition you and club have yet to substantiate is that current levels of R&D are optimal from a societal standpoint. I contend they are not, and that regulation could move us closer to that optimal point.
